Laniquidar TFA
Laniquidar (R101933) is a novel, orally available non-competitive P-glycoprotein inhibitor (IC50 = 0.51 μM) used to study multidrug resistance modulation. Its research applications include investigating acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
98.74% (May vary between batches)
Smiles
O=C (C1=CN=C2/C (C3=C (CCN21) C=CC=C3) =C4CCN (CC\4) CCC5=CC=C (C=C5) OCC6=NC7=C (C=C6) C=CC=C7) OC.OC (C (F) (F) F) =O
Molecular Formula
C39H37F3N4O5
Molecular Weight
698.73
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4194701 3x 1.0 µg
Olfr237-ps1 sgRNA CRISPR Lentivector set (Mouse)
Sign In for Pricing
View Details 
